News
GSK claims first approval for Nucala in COPD
GSK gets FDA approval for Nucala in COPD, setting up a marketing tussle with Sanofi/Regeneron's Dupixent.
News
Digital player Hinge Health rises sharply after NYSE debut
In a signal of a return to investor appetite for digital health stocks, Hinge Health has raised an impressive $437 million in an IPO.
Sales & Marketing
The exponential imperative: Rethinking biopharma strategy fo...
The biopharma industry – long a powerhouse of scientific innovation – now stands at a critical inflection point.
News
Mixed outcomes for pharma in big week for FDA adcomms
There was good news for Johnson & Johnson at this week's ODAC meetings, but not for Roche, UroGen, and Pfizer.
News
First details of Trump's most favoured nation plan emerge
Donald Trump's plan to introduce a most favoured nation (MFN) system of drug pricing controls is not quite what he first said it would be.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
